Advances in gene therapy for hemophilia

Hemophilia is a hereditary disorder that can be life-threatening in individuals who have severe spontaneous bleeding resulting from minor trauma or surgery. Although replacement therapy of the missing exogenous factor has improved patients’ quality of life, it has not been possible to establish a lo...

Full description

Saved in:
Bibliographic Details
Published in:Journal of biosciences 2020-12, Vol.45 (1), Article 88
Main Authors: Robles-Rodríguez, Olivia A, Pérez-Trujillo, José J, Villanueva-Olivo, Arnulfo, Villarreal-Martínez, Laura, Marfil-Rivera, Luis J, Rodríguez-Rocha, Humberto, García-García, Aracely, Saucedo-Cárdenas, Odila, Loera-Arias, María J, de Oca-Luna, Roberto Montes
Format: Article
Language:English
Subjects:
Biomedical and Life Sciences
Biomedicine
Bleeding
Cell Biology
Gene therapy
Hemophilia
Life Sciences
Microbiology
Patients
Plant Sciences
Quality of life
Review
Surgery
Sustainable development
Trauma
Zoology
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c380t-524a982e4ae410479e9eeabb0fd2b220636523734990d576cf8d513e1c0d786e3
cites cdi_FETCH-LOGICAL-c380t-524a982e4ae410479e9eeabb0fd2b220636523734990d576cf8d513e1c0d786e3
container_end_page
container_issue 1
container_start_page
container_title Journal of biosciences
container_volume 45
creator Robles-Rodríguez, Olivia A
Pérez-Trujillo, José J
Villanueva-Olivo, Arnulfo
Villarreal-Martínez, Laura
Marfil-Rivera, Luis J
Rodríguez-Rocha, Humberto
García-García, Aracely
Saucedo-Cárdenas, Odila
Loera-Arias, María J
de Oca-Luna, Roberto Montes
description Hemophilia is a hereditary disorder that can be life-threatening in individuals who have severe spontaneous bleeding resulting from minor trauma or surgery. Although replacement therapy of the missing exogenous factor has improved patients’ quality of life, it has not been possible to establish a long-term treatment. Due to the severity of the disease and the need for repetitive doses throughout the patient’s life, replacement therapy has become a high-cost treatment option; therefore, the development of self-sustainable long-term therapies is critical. Hemophilia is a good candidate for gene therapy because it is a monogenic disease that can be counteracted by expression of the missing factor. In this article, we review some of the most relevant advances in gene therapy for this illness.
doi_str_mv 10.1007/s12038-020-00057-y
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2423801530</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2489441487</sourcerecordid><originalsourceid>FETCH-LOGICAL-c380t-524a982e4ae410479e9eeabb0fd2b220636523734990d576cf8d513e1c0d786e3</originalsourceid><addsrcrecordid>eNp9kE1Lw0AQhhdRsFb_gKeAB72szn5ld4-lWBUKXvS8bJNJm5ImcbcV8u9djSB46Gnm8LzvDA8h1wzuGYB-iIyDMBQ4UABQmg4nZAJWC6qZMKdp5wqospadk4sYtwDMSgETcjsrP31bYMzqNltji9l-g8H3Q1Z1Idvgrus3dVP7S3JW-Sbi1e-ckvfF49v8mS5fn17msyUthIE9VVx6azhKj5KB1BYtol-toCr5inPIRa640EJaC6XSeVGZUjGBrIBSmxzFlNyNvX3oPg4Y925XxwKbxrfYHaLjkqdDTAlI6M0_dNsdQpu-S5SxUjJp9HGKWaW0BZ4oPlJF6GIMWLk-1DsfBsfAfRt2o2GXDLsfw25IITGGYoLbNYa_6iOpL_J0eu4</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2419557902</pqid></control><display><type>article</type><title>Advances in gene therapy for hemophilia</title><source>Springer Nature</source><creator>Robles-Rodríguez, Olivia A ; Pérez-Trujillo, José J ; Villanueva-Olivo, Arnulfo ; Villarreal-Martínez, Laura ; Marfil-Rivera, Luis J ; Rodríguez-Rocha, Humberto ; García-García, Aracely ; Saucedo-Cárdenas, Odila ; Loera-Arias, María J ; de Oca-Luna, Roberto Montes</creator><creatorcontrib>Robles-Rodríguez, Olivia A ; Pérez-Trujillo, José J ; Villanueva-Olivo, Arnulfo ; Villarreal-Martínez, Laura ; Marfil-Rivera, Luis J ; Rodríguez-Rocha, Humberto ; García-García, Aracely ; Saucedo-Cárdenas, Odila ; Loera-Arias, María J ; de Oca-Luna, Roberto Montes</creatorcontrib><description>Hemophilia is a hereditary disorder that can be life-threatening in individuals who have severe spontaneous bleeding resulting from minor trauma or surgery. Although replacement therapy of the missing exogenous factor has improved patients’ quality of life, it has not been possible to establish a long-term treatment. Due to the severity of the disease and the need for repetitive doses throughout the patient’s life, replacement therapy has become a high-cost treatment option; therefore, the development of self-sustainable long-term therapies is critical. Hemophilia is a good candidate for gene therapy because it is a monogenic disease that can be counteracted by expression of the missing factor. In this article, we review some of the most relevant advances in gene therapy for this illness.</description><identifier>ISSN: 0250-5991</identifier><identifier>EISSN: 0973-7138</identifier><identifier>DOI: 10.1007/s12038-020-00057-y</identifier><language>eng</language><publisher>New Delhi: Springer India</publisher><subject>Biomedical and Life Sciences ; Biomedicine ; Bleeding ; Cell Biology ; Gene therapy ; Hemophilia ; Life Sciences ; Microbiology ; Patients ; Plant Sciences ; Quality of life ; Review ; Surgery ; Sustainable development ; Trauma ; Zoology</subject><ispartof>Journal of biosciences, 2020-12, Vol.45 (1), Article 88</ispartof><rights>Indian Academy of Sciences 2020</rights><rights>Indian Academy of Sciences 2020.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c380t-524a982e4ae410479e9eeabb0fd2b220636523734990d576cf8d513e1c0d786e3</citedby><cites>FETCH-LOGICAL-c380t-524a982e4ae410479e9eeabb0fd2b220636523734990d576cf8d513e1c0d786e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids></links><search><creatorcontrib>Robles-Rodríguez, Olivia A</creatorcontrib><creatorcontrib>Pérez-Trujillo, José J</creatorcontrib><creatorcontrib>Villanueva-Olivo, Arnulfo</creatorcontrib><creatorcontrib>Villarreal-Martínez, Laura</creatorcontrib><creatorcontrib>Marfil-Rivera, Luis J</creatorcontrib><creatorcontrib>Rodríguez-Rocha, Humberto</creatorcontrib><creatorcontrib>García-García, Aracely</creatorcontrib><creatorcontrib>Saucedo-Cárdenas, Odila</creatorcontrib><creatorcontrib>Loera-Arias, María J</creatorcontrib><creatorcontrib>de Oca-Luna, Roberto Montes</creatorcontrib><title>Advances in gene therapy for hemophilia</title><title>Journal of biosciences</title><addtitle>J Biosci</addtitle><description>Hemophilia is a hereditary disorder that can be life-threatening in individuals who have severe spontaneous bleeding resulting from minor trauma or surgery. Although replacement therapy of the missing exogenous factor has improved patients’ quality of life, it has not been possible to establish a long-term treatment. Due to the severity of the disease and the need for repetitive doses throughout the patient’s life, replacement therapy has become a high-cost treatment option; therefore, the development of self-sustainable long-term therapies is critical. Hemophilia is a good candidate for gene therapy because it is a monogenic disease that can be counteracted by expression of the missing factor. In this article, we review some of the most relevant advances in gene therapy for this illness.</description><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Bleeding</subject><subject>Cell Biology</subject><subject>Gene therapy</subject><subject>Hemophilia</subject><subject>Life Sciences</subject><subject>Microbiology</subject><subject>Patients</subject><subject>Plant Sciences</subject><subject>Quality of life</subject><subject>Review</subject><subject>Surgery</subject><subject>Sustainable development</subject><subject>Trauma</subject><subject>Zoology</subject><issn>0250-5991</issn><issn>0973-7138</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNp9kE1Lw0AQhhdRsFb_gKeAB72szn5ld4-lWBUKXvS8bJNJm5ImcbcV8u9djSB46Gnm8LzvDA8h1wzuGYB-iIyDMBQ4UABQmg4nZAJWC6qZMKdp5wqospadk4sYtwDMSgETcjsrP31bYMzqNltji9l-g8H3Q1Z1Idvgrus3dVP7S3JW-Sbi1e-ckvfF49v8mS5fn17msyUthIE9VVx6azhKj5KB1BYtol-toCr5inPIRa640EJaC6XSeVGZUjGBrIBSmxzFlNyNvX3oPg4Y925XxwKbxrfYHaLjkqdDTAlI6M0_dNsdQpu-S5SxUjJp9HGKWaW0BZ4oPlJF6GIMWLk-1DsfBsfAfRt2o2GXDLsfw25IITGGYoLbNYa_6iOpL_J0eu4</recordid><startdate>20201201</startdate><enddate>20201201</enddate><creator>Robles-Rodríguez, Olivia A</creator><creator>Pérez-Trujillo, José J</creator><creator>Villanueva-Olivo, Arnulfo</creator><creator>Villarreal-Martínez, Laura</creator><creator>Marfil-Rivera, Luis J</creator><creator>Rodríguez-Rocha, Humberto</creator><creator>García-García, Aracely</creator><creator>Saucedo-Cárdenas, Odila</creator><creator>Loera-Arias, María J</creator><creator>de Oca-Luna, Roberto Montes</creator><general>Springer India</general><general>Springer Nature B.V</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7TM</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>8AO</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>F1W</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H99</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>L.F</scope><scope>L.G</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>M7P</scope><scope>MBDVC</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>20201201</creationdate><title>Advances in gene therapy for hemophilia</title><author>Robles-Rodríguez, Olivia A ; Pérez-Trujillo, José J ; Villanueva-Olivo, Arnulfo ; Villarreal-Martínez, Laura ; Marfil-Rivera, Luis J ; Rodríguez-Rocha, Humberto ; García-García, Aracely ; Saucedo-Cárdenas, Odila ; Loera-Arias, María J ; de Oca-Luna, Roberto Montes</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c380t-524a982e4ae410479e9eeabb0fd2b220636523734990d576cf8d513e1c0d786e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Bleeding</topic><topic>Cell Biology</topic><topic>Gene therapy</topic><topic>Hemophilia</topic><topic>Life Sciences</topic><topic>Microbiology</topic><topic>Patients</topic><topic>Plant Sciences</topic><topic>Quality of life</topic><topic>Review</topic><topic>Surgery</topic><topic>Sustainable development</topic><topic>Trauma</topic><topic>Zoology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Robles-Rodríguez, Olivia A</creatorcontrib><creatorcontrib>Pérez-Trujillo, José J</creatorcontrib><creatorcontrib>Villanueva-Olivo, Arnulfo</creatorcontrib><creatorcontrib>Villarreal-Martínez, Laura</creatorcontrib><creatorcontrib>Marfil-Rivera, Luis J</creatorcontrib><creatorcontrib>Rodríguez-Rocha, Humberto</creatorcontrib><creatorcontrib>García-García, Aracely</creatorcontrib><creatorcontrib>Saucedo-Cárdenas, Odila</creatorcontrib><creatorcontrib>Loera-Arias, María J</creatorcontrib><creatorcontrib>de Oca-Luna, Roberto Montes</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Nucleic Acids Abstracts</collection><collection>ProQuest Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>ASFA: Aquatic Sciences and Fisheries Abstracts</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ASFA: Marine Biotechnology Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Aquatic Science &amp; Fisheries Abstracts (ASFA) Marine Biotechnology Abstracts</collection><collection>Aquatic Science &amp; Fisheries Abstracts (ASFA) Professional</collection><collection>Biological Sciences</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest research library</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of biosciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Robles-Rodríguez, Olivia A</au><au>Pérez-Trujillo, José J</au><au>Villanueva-Olivo, Arnulfo</au><au>Villarreal-Martínez, Laura</au><au>Marfil-Rivera, Luis J</au><au>Rodríguez-Rocha, Humberto</au><au>García-García, Aracely</au><au>Saucedo-Cárdenas, Odila</au><au>Loera-Arias, María J</au><au>de Oca-Luna, Roberto Montes</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Advances in gene therapy for hemophilia</atitle><jtitle>Journal of biosciences</jtitle><stitle>J Biosci</stitle><date>2020-12-01</date><risdate>2020</risdate><volume>45</volume><issue>1</issue><artnum>88</artnum><issn>0250-5991</issn><eissn>0973-7138</eissn><abstract>Hemophilia is a hereditary disorder that can be life-threatening in individuals who have severe spontaneous bleeding resulting from minor trauma or surgery. Although replacement therapy of the missing exogenous factor has improved patients’ quality of life, it has not been possible to establish a long-term treatment. Due to the severity of the disease and the need for repetitive doses throughout the patient’s life, replacement therapy has become a high-cost treatment option; therefore, the development of self-sustainable long-term therapies is critical. Hemophilia is a good candidate for gene therapy because it is a monogenic disease that can be counteracted by expression of the missing factor. In this article, we review some of the most relevant advances in gene therapy for this illness.</abstract><cop>New Delhi</cop><pub>Springer India</pub><doi>10.1007/s12038-020-00057-y</doi></addata></record>
fulltext fulltext
identifier ISSN: 0250-5991
ispartof Journal of biosciences, 2020-12, Vol.45 (1), Article 88
issn 0250-5991
0973-7138
language eng
recordid cdi_proquest_miscellaneous_2423801530
source Springer Nature
subjects Biomedical and Life Sciences
Biomedicine
Bleeding
Cell Biology
Gene therapy
Hemophilia
Life Sciences
Microbiology
Patients
Plant Sciences
Quality of life
Review
Surgery
Sustainable development
Trauma
Zoology
title Advances in gene therapy for hemophilia
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-25T23%3A46%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Advances%20in%20gene%20therapy%20for%20hemophilia&rft.jtitle=Journal%20of%20biosciences&rft.au=Robles-Rodr%C3%ADguez,%20Olivia%20A&rft.date=2020-12-01&rft.volume=45&rft.issue=1&rft.artnum=88&rft.issn=0250-5991&rft.eissn=0973-7138&rft_id=info:doi/10.1007/s12038-020-00057-y&rft_dat=%3Cproquest_cross%3E2489441487%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c380t-524a982e4ae410479e9eeabb0fd2b220636523734990d576cf8d513e1c0d786e3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2419557902&rft_id=info:pmid/&rfr_iscdi=true